Your browser doesn't support javascript.
loading
Iontophoresis for the cutaneous delivery of nanoentraped drugs.
Andrade, Jayanaraian F M; Cunha-Filho, Marcilio; Gelfuso, Guilherme M; Gratieri, Tais.
Afiliação
  • Andrade JFM; School of Health Sciences, Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasilia, DF, Brazil.
  • Cunha-Filho M; School of Health Sciences, Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasilia, DF, Brazil.
  • Gelfuso GM; School of Health Sciences, Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasilia, DF, Brazil.
  • Gratieri T; School of Health Sciences, Laboratory of Food, Drugs, and Cosmetics (LTMAC), University of Brasilia, Brasilia, DF, Brazil.
Expert Opin Drug Deliv ; 20(6): 785-798, 2023 06.
Article em En | MEDLINE | ID: mdl-37119173
ABSTRACT

INTRODUCTION:

The skin is an attractive route for drug delivery. However, the stratum corneum is a critical limiting barrier for drug permeation. Nanoentrapment is a way to enhance cutaneous drug delivery, by diverse mechanisms, with a notable trend of nanoparticles accumulating into the hair follicles when topically applied. Iontophoresis is yet another way of increasing drug transport by applying a mild electrical field that preferentially passes through the hair follicles, for being the pathway of lower resistance. So, iontophoresis application to nanocarriers could further increase actives accumulation into the hair follicles, impacting cutaneous drug delivery. AREAS COVERED In this review, the authors aimed to discuss the main factors impacting iontophoretic skin transport when combining nanocarriers with iontophoresis. We further provide an overview of the conditions in which this combination has been studied, the characteristics of nanosystems employed, and hypothesize why the association has succeeded or failed to enhance drug permeation. EXPERT OPINION Nanocarriers and iontophoresis association can be promising to enhance cutaneous drug delivery. For better results, the electroosmotic contribution to the iontophoretic transport, mainly of negatively charged nanocarriers, charge density, formulation pH, and skin models should be considered. Moreover, the transfollicular pathway should be considered, especially when designing the nanocarriers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Iontoforese Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Iontoforese Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article